LONDON, July 25, 2014 /PRNewswire/ --
Investor-Edge.com has issued complimentary earnings and equity performance review on Allergan Inc. (NYSE: AGN). The company was recently featured in the headlines on Monday, July 21, 2014, for reporting a 15.9% year-over-year surge in total product net sales in the second quarter of 2014. Our free coverage report can be accessed at:
http://www.investor-edge.com/register
Earnings Overview
Allergan Inc.'s non-GAAP diluted earnings per share attributable to stockholders surged 23.8% year-over-year during the second quarter of 2014. The multi-specialty health care company reported GAAP diluted earnings per share attributable to stockholders of $1.37, compared with $1.17 GAAP diluted earnings per share attributable to stockholders for the second quarter of 2013. The free research on AGN can be downloaded as in PDF format at:
http://www.Investor-Edge.com/AGNFreerSearchReport
David E.I. Pyott, Allergan's Chairman and Chief Executive Officer, stated in a recent press release that the company has reported the strongest increase in absolute dollar sales in any quarter in its history and has been able to deliver sales and earnings per share growth above the company's expectation during Q2 2014.
The Irvine, California-based company outperformed market expectations by reporting better-than-expected revenues for the second quarter of 2014. Allergan Inc.'s total product net sales of $1.83 billion were above Bloomberg consensus estimate of $1.77 billion. The healthcare major reported Non-GAAP diluted earnings per share attributable to stockholders of $1.51 a share compared with $1.22 a share in the year-ago quarter. The company's GAAP diluted earnings per share attributable to stockholders stood at $1.37 a share, underperforming the market consensus estimate of $1.43 a share. On July 21, 2014, Allergan also declared a quarterly dividend of $0.05 a share, payable on September 5, 2014 to shareholders of record as of the close of business on August 15, 2014. Sign up and read the free analyst's notes on AGN at:
http://www.Investor-Edge.com/AGN -24Jul2014
Stock Performance
Allergan Inc.'s shares gained 2.23% following the earnings release on Monday, July 21, 2014, to end the session at $171.14. However, on the last close, Thursday, July 24, 2014, the stock fell 1.08% to close at $170.57. The stock vacillated between $168.56 and $172.35 during the session. A total of 1.58 million shares were traded, which was below its three months average volume of 3.40 million shares. Over the last one month and over the previous three months, the company's shares have advanced 3.16% and 2.38%, respectively. Additionally, from the beginning of 2014, the stock has gained 53.56%. Allergan Inc.'s shares are trading above their 50-day and 200-day moving averages. Moreover, the stock's 50-day moving average of $165.20 is greater than its 200-day moving average of $128.40. The stock traded at a PE ratio of 33.21 and has a Relative Strength Index (RSI) of 62.83. Visit Investor-Edge and access the latest research on AGN at:
http://www.Investor-Edge.com/AGNEarningsCoverage
Sneak Peek to Corporate Insider Trading
In the last one month, the company has not reported any share transactions by insiders to the U.S. Securities and Exchange Commission (SEC). Complimentary in-depth research on AGN is available at:
http://www.Investor-Edge.com/AGNInsiderTrading
Source:
http://agn.client.shareholder.com/releasedetail.cfm?ReleaseID=860851
Insider trading Source:
http://insidertrading.org/'sort_by=acceptance_datetime&asc=&symbol=AGN&date_from=2014-06-23&date_to=2014-07-23&submit=+GO+
(See the file attached for data)
About Investor-Edge.com
At Investor-Edge, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Investor-Edge comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.investor-edge.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Investor-Edge
